Brand Name | Status | Last Update |
---|---|---|
diluent flolan | New Drug Application | 2023-10-26 |
epoprostenol | ANDA | 2021-01-16 |
flolan | New Drug Application | 2016-06-22 |
veletri | New Drug Application | 2022-11-28 |
Code | Description |
---|---|
J1325 | Injection, epoprostenol, 0.5 mg |
K0455 | Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol) |
S0155 | Sterile dilutant for epoprostenol, 50 ml |
S9347 | Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pulmonary arterial hypertension | D000081029 | — | — | 2 | 9 | 7 | 8 | 9 | 35 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | 4 | 5 | 8 | 4 | 22 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | 3 | 1 | 1 | 5 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 2 | 1 | 3 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | 2 | 1 | — | 3 |
Platelet aggregation | D010974 | GO_0070527 | — | — | — | — | 1 | — | 1 |
Pulmonary embolism | D011655 | HP_0002204 | I26 | — | — | — | 1 | — | 1 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | — | 1 | — | 1 |
Vitiligo | D014820 | EFO_0004208 | L80 | — | — | — | 1 | — | 1 |
Excimer lasers | D054018 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Familial primary pulmonary hypertension | D065627 | — | I27.0 | — | — | 5 | — | 2 | 7 |
Hypertension | D006973 | EFO_0000537 | I10 | — | — | 3 | — | — | 3 |
Respiratory tract diseases | D012140 | — | — | — | — | 3 | — | — | 3 |
Connective tissue diseases | D003240 | EFO_1001986 | M35 | — | — | 3 | — | — | 3 |
Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | 3 | — | — | 3 |
Lung diseases | D008171 | HP_0002088 | J98.4 | — | — | 3 | — | — | 3 |
Liver transplantation | D016031 | EFO_0010682 | — | — | 1 | 1 | — | — | 1 |
Septic shock | D012772 | — | A48.3 | — | 1 | 1 | — | — | 1 |
Arterial occlusive diseases | D001157 | EFO_0009085 | — | — | — | 1 | — | — | 1 |
Cerebral small vessel diseases | D059345 | — | — | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Reperfusion injury | D015427 | — | — | 2 | 2 | — | — | — | 3 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 1 | — | — | 1 | 2 |
Covid-19 | D000086382 | — | U07.1 | — | 2 | — | — | — | 2 |
Schistosomiasis | D012552 | EFO_1001475 | B65 | — | 1 | — | — | — | 1 |
Delayed graft function | D051799 | — | — | 1 | 1 | — | — | — | 1 |
Persistent fetal circulation syndrome | D010547 | EFO_1001103 | P29.3 | — | 1 | — | — | — | 1 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | — | — | 1 |
Respiratory insufficiency | D012131 | HP_0002093 | J96.9 | — | 1 | — | — | — | 1 |
Multiple organ failure | D009102 | EFO_1001373 | — | — | 1 | — | — | — | 1 |
Heart arrest | D006323 | EFO_0009492 | I46 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | 1 | — | — | — | 1 | 2 |
Headache | D006261 | HP_0002315 | R51 | 1 | — | — | — | 1 | 2 |
Traumatic brain injuries | D000070642 | — | S06 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | — | — | — | — | 2 | 2 |
Congenital heart defects | D006330 | HP_0001627 | Q24.9 | — | — | — | — | 2 | 2 |
Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | — | — | — | — | 2 | 2 |
Eisenmenger complex | D004541 | — | I27.83 | — | — | — | — | 1 | 1 |
Asthma | D001249 | EFO_0000270 | J45 | — | — | — | — | 1 | 1 |
Chronic cough | D000096822 | — | R05.3 | — | — | — | — | 1 | 1 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 1 | 1 |
Primary myelofibrosis | D055728 | — | D47.4 | — | — | — | — | 1 | 1 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
Vasodilation | D014664 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Epoprostenol |
INN | epoprostenol |
Description | Prostaglandin I2 is a prostaglandins I. It has a role as a mouse metabolite. It is a conjugate acid of a prostaglandin I2(1-). |
Classification | Small molecule |
Drug class | prostaglandins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\CCCC(=O)O)C[C@@H]21 |
PDB | — |
CAS-ID | 35121-78-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1139 |
ChEBI ID | 15552 |
PubChem CID | 5282411 |
DrugBank | DB01240 |
UNII ID | DCR9Z582X0 (ChemIDplus, GSRS) |